<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>&lt;i&gt;Clostridioides difficile&lt;/i&gt; infection in children: Clinical features and diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center"><i>Clostridioides difficile</i> infection in children: Clinical features and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle"><i>Clostridioides difficile</i> infection in children: Clinical features and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan Crews, MD, MS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Maribeth R Nicholson, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 26, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span><em>Clostridioides</em> <em>difficile</em> is an important cause of antibiotic-associated diarrhea and one of the most common health care-associated pathogens [<a href="#rid1">1</a>]. Its clinical manifestations range from asymptomatic colonization or mild diarrhea to fulminant disease characterized by ileus, toxic megacolon, hypotension, or shock. <em>C. difficile</em> infection is less common in children than adults, but the incidence of <em>C. difficile</em> infection in children is increasing [<a href="#rid2">2-5</a>].</p><p>The clinical features and diagnosis of <em>C. difficile</em> infection in children will be discussed here. The microbiology, pathogenesis, epidemiology, treatment, and prevention of <em>C. difficile</em> infection in children and <em>C. difficile</em> infection in adults are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6041.html" rel="external">"<i>Clostridioides difficile</i> infection in children: Microbiology, pathogenesis, and epidemiology"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6050.html" rel="external">"<i>Clostridioides difficile</i> infection in children: Treatment and outcome"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2687.html" rel="external">"<i>Clostridioides difficile</i> infection: Prevention and control"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2696.html" rel="external">"<i>Clostridioides difficile </i>infection in adults: Epidemiology, microbiology, and pathophysiology"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2699.html" rel="external">"<i>Clostridioides difficile </i>infection in adults: Clinical manifestations and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2698.html" rel="external">"<i>Clostridioides difficile</i> infection in adults: Treatment and prevention"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">CLINICAL SPECTRUM</span><span class="headingEndMark"> — </span>The clinical spectrum of <em>C. difficile</em> infection ranges from asymptomatic colonization to fulminant colitis [<a href="#rid6">6,7</a>]. The severity of infection generally increases with age. Mortality and fulminant disease are highest in persons ≥65 years and uncommon in children [<a href="#rid1">1,2,8,9</a>]. However, the full spectrum of disease is possible in all age groups [<a href="#rid6">6,10,11</a>].</p><p class="headingAnchor" id="H3047506279"><span class="h2">Asymptomatic colonization</span><span class="headingEndMark"> — </span>Asymptomatic carriers may be a reservoir of <em>C. difficile </em>[<a href="#rid12">12,13</a>]. (See  <a class="medical medical_review" href="/z/d/html/6041.html" rel="external">"<i>Clostridioides difficile</i> infection in children: Microbiology, pathogenesis, and epidemiology", section on 'Colonization'</a>.)</p><p class="headingAnchor" id="H5"><span class="h3">Neonates and children &lt;2 years of age</span><span class="headingEndMark"> — </span>Asymptomatic colonization with toxigenic <em>C. difficile</em> is common in neonates and infants [<a href="#rid6">6,14</a>]. A meta-analysis of observational studies estimated the proportion of colonization with <em>C. difficile</em> increased from 15 percent (95% CI 7-25 percent) in neonates &lt;7 days of age to 41 percent (95% CI 32-50 percent) in infants 6 to 12 months of age, the peak of asymptomatic colonization [<a href="#rid15">15</a>]. Colonization with toxigenic <em>C. difficile</em> increased from ≤6 percent in infants &lt;3 months of age to 14 percent (95% CI 8-21 percent) in infants 6 to 12 months of age. (See  <a class="medical medical_review" href="/z/d/html/6041.html" rel="external">"<i>Clostridioides difficile</i> infection in children: Microbiology, pathogenesis, and epidemiology", section on 'Epidemiology'</a>.)</p><p>Multiple studies have failed to demonstrate a clear association between the detection of <em>C. difficile</em> toxins and diarrheal illness in children younger than two years [<a href="#rid16">16-23</a>]. The causes of this apparent resistance to illness are unknown. However, there are data to suggest that <em>C. difficile</em> can be pathogenic in infants and young children in select circumstances [<a href="#rid11">11</a>]. (See <a class="local">'Symptomatic disease'</a> below.)</p><p>The age at which children become universally susceptible to <em>C. difficile</em> infection is unknown [<a href="#rid11">11</a>]. Coinfection with additional intestinal pathogens is common in this age group but does not appear to be associated with increased illness severity [<a href="#rid19">19,20,24-26</a>]. (See  <a class="medical medical_review" href="/z/d/html/6041.html" rel="external">"<i>Clostridioides difficile</i> infection in children: Microbiology, pathogenesis, and epidemiology", section on 'Pathogenesis'</a>.)</p><p class="headingAnchor" id="H4130030430"><span class="h3">Hospitalized children and children with comorbidities</span><span class="headingEndMark"> — </span>Asymptomatic carriage has been described in hospitalized children and children with comorbidities [<a href="#rid14">14,27</a>]. In a single study of hospitalized children, similar proportions of symptomatic and asymptomatic patients had a positive <em>C. difficile</em> polymerase chain reaction assay [<a href="#rid27">27</a>]. Several observational studies suggest a colonization prevalence of 15 to 30 percent in children with cancer, 33 to 50 percent in children with cystic fibrosis, and 11 to 17 percent in children with inflammatory bowel disease [<a href="#rid27">27-31</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Symptomatic disease</span></p><p class="headingAnchor" id="H7"><span class="h3">Diarrhea</span><span class="headingEndMark"> — </span>Symptoms of <em>C. difficile</em> infection typically begin either during or several weeks after antibiotic therapy; occasionally the onset is delayed for as long as 10 weeks. Acute-onset, mild to moderate diarrhea is the most common feature of symptomatic <em>C. difficile</em> infection [<a href="#rid32">32-34</a>]. The diarrhea is watery and profuse; some children have &gt;10 stools per day at the peak of the illness. Stools with grossly visible blood are uncommon, occurring in &lt;15 percent of episodes [<a href="#rid32">32-34</a>]. Fever and lower abdominal cramping or pain are common and vomiting can occur [<a href="#rid35">35</a>]. The physical examination may demonstrate lower abdominal tenderness [<a href="#rid36">36</a>].</p><p>In a case series of 109 children (age 1 to 18 years) with <em>C. difficile</em> infection at a tertiary care children's hospital, the clinical features included fever (37 percent), abdominal pain (46 percent), and diarrhea with grossly visible blood (14 percent); the majority of children passed ≥6 stools per day during the peak of the illness [<a href="#rid34">34</a>].</p><p class="headingAnchor" id="H4159325414"><span class="h3">Severe disease</span><span class="headingEndMark"> — </span>There are several challenges to establishing the diagnosis of severe disease in pediatric <em>C. difficile</em> infection. There is no strict consensus on disease definitions, and adult scoring systems have not been validated in children.</p><p>We use the following clinical features to suggest severe <em>C. difficile</em> infection in children (<a class="graphic graphic_table graphicRef100705" href="/z/d/graphic/100705.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Profuse diarrhea with systemic findings (fever, rigors, or severe abdominal pain, tenderness, or distention)</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated white blood cell count (&gt;15,000 cells/microL)</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated age-adjusted serum creatinine level</p><p class="bulletIndent1"><span class="glyph">●</span>Pseudomembranous colitis (discussed below)</p><p></p><p>Children with features of severe disease may warrant more aggressive treatment. (See  <a class="medical medical_review" href="/z/d/html/6050.html" rel="external">"<i>Clostridioides difficile</i> infection in children: Treatment and outcome"</a>.)</p><p class="headingAnchor" id="H8"><span class="h3">Pseudomembranous colitis</span><span class="headingEndMark"> — </span>Pseudomembranous colitis (severe inflammation of the inner lining of the bowel) from <em>C. difficile</em> infection is uncommon in children. There are limited descriptions of pseudomembranous colitis in children, possibly because children with <em>C. difficile</em> infection often are diagnosed without endoscopy.</p><p>Intestinal perforation, ileocolic intussusception, pneumatosis intestinalis, and rectal prolapse (with pseudomembranes visible on the extruded segment) are rare manifestations [<a href="#rid37">37-42</a>]. Paralytic ileus may lead to a paradoxical absence of stool, which may delay diagnosis. Severe cases may have radiographic findings (ie, mucosal thickening, "thumbprinting" (<a class="graphic graphic_diagnosticimage graphicRef52929" href="/z/d/graphic/52929.html" rel="external">image 1A</a>), dilation). (See <a class="local">'Radiographic features'</a> below.)</p><p>There are reports of severe or fatal pseudomembranous colitis in neonates and infants younger than two years [<a href="#rid43">43-47</a>]. Some, but not all, cases had an identifiable risk factor such as antibiotic exposure. Other reported cases occurred in infants with gastrointestinal obstruction or prematurity but no other explanation for pseudomembranous colitis. However, given the high frequency of toxigenic <em>C. difficile</em> carriage in this age group, it is difficult to know definitively whether <em>C. difficile</em> was a causal or incidental finding.</p><p>The diagnosis of pseudomembranous colitis is confirmed by visualization of pseudomembranes on endoscopy or histologic examination of biopsied tissue. Although not usually performed in children, sigmoidoscopy or colonoscopy demonstrates characteristic adherent yellow plaques (<a class="graphic graphic_picture graphicRef53774 graphicRef62422" href="/z/d/graphic/53774.html" rel="external">picture 1A-B</a>). Immediate treatment is crucial to prevent progression to more fulminant disease. (See  <a class="medical medical_review" href="/z/d/html/6050.html" rel="external">"<i>Clostridioides difficile</i> infection in children: Treatment and outcome", section on 'Severe disease'</a>.)</p><p class="headingAnchor" id="H2346358481"><span class="h3">Fulminant disease</span><span class="headingEndMark"> — </span>Fulminant <em>C. difficile</em> infection is characterized by ileus, toxic megacolon, hypotension, or shock (<a class="graphic graphic_table graphicRef100705" href="/z/d/graphic/100705.html" rel="external">table 1</a>). The manifestations of fulminant infection can include fever, diarrhea, severe lower quadrant or diffuse abdominal pain, abdominal distention, hypovolemia, leukocytosis, hypoalbuminemia, and lactic acidosis [<a href="#rid48">48,49</a>]. Diarrhea may be absent in patients with prolonged ileus.</p><p>Potential complications of fulminant colitis include toxic megacolon and bowel perforation [<a href="#rid50">50</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Toxic megacolon is a clinical diagnosis based upon radiographic evidence of colonic dilatation associated with severe systemic toxicity. Abdominal radiographs may demonstrate small bowel dilatation, air-fluid levels (mimicking an intestinal obstruction), and "thumbprinting" (scalloping of the bowel wall) due to submucosal edema (<a class="graphic graphic_diagnosticimage graphicRef52929" href="/z/d/graphic/52929.html" rel="external">image 1A</a> and <a class="graphic graphic_diagnosticimage graphicRef59217" href="/z/d/graphic/59217.html" rel="external">image 2</a>). (See  <a class="medical medical_review" href="/z/d/html/1381.html" rel="external">"Toxic megacolon"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bowel perforation presents with abdominal rigidity, involuntary guarding, diminished bowel sounds, rebound tenderness, and severe localized tenderness in the left or right lower quadrants. Abdominal radiographs may demonstrate free abdominal air.</p><p></p><p>Aggressive diagnostic and therapeutic interventions are warranted in the setting of fulminant <em>C. difficile</em> infection. Prompt surgical consultation is warranted to assess the need for surgical intervention [<a href="#rid51">51</a>]. (See  <a class="medical medical_review" href="/z/d/html/6050.html" rel="external">"<i>Clostridioides difficile</i> infection in children: Treatment and outcome", section on 'Fulminant disease'</a>.)</p><p class="headingAnchor" id="H2082343370"><span class="h3">Extracolonic findings</span><span class="headingEndMark"> — </span>Rare cases of extracolonic infection from <em>C. difficile</em> have been described in children, including skin and soft tissue infections, bacteremia, and osteomyelitis [<a href="#rid52">52-54</a>]. Reactive arthritis associated with <em>C. difficile</em> infection has also been described in adults and children [<a href="#rid52">52,55-58</a>]. (See  <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">"Reactive arthritis", section on 'Preceding infection'</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Recurrent infection</span><span class="headingEndMark"> — </span>Recurrence occurs in 12 to 30 percent of children with <em>C. difficile</em> infection [<a href="#rid32">32,34,35,59-61</a>]. Some children have multiple recurrences which can be refractory to conventional treatments.</p><p>Recurrent <em>C. difficile</em> infection is a return of symptoms with a positive assay result after a period of initial symptom resolution that occurs within eight weeks after the initial episode (typically within one to three weeks) [<a href="#rid62">62-64</a>]. The signs and symptoms of recurrence are typically similar to those of the initial episode.</p><p>Recurrent episodes may represent a relapse of the previous infecting strain or reinfection with a new strain [<a href="#rid65">65</a>]. The mechanism of recurrent disease is poorly understood. The persistence of dormant spores within the intestines, low levels of antitoxin antibody levels, and continued disturbance of intestinal flora are thought to contribute to recurrent disease [<a href="#rid7">7,66,67</a>]. Antibiotic resistance has not been shown to be a factor in recurrence.</p><p>In observational studies, recurrent <em>C. difficile</em> infection in children has been associated with community-associated disease, receipt of concomitant antibiotics, malignancy, tracheostomy tube dependence, recent surgery, the number of classes of antibiotic exposure, and increased inflammatory markers in stool (eg, lactoferrin, calprotectin, interleukin-8) at the time of initial infection [<a href="#rid35">35,60,68,69</a>].</p><p>Management of recurrent <em>C. difficile</em> infection is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6050.html" rel="external">"<i>Clostridioides difficile</i> infection in children: Treatment and outcome", section on 'Management of recurrence'</a>.)</p><p class="headingAnchor" id="H13"><span class="h1">LABORATORY FEATURES</span><span class="headingEndMark"> — </span>Ancillary laboratory studies are not necessary for the diagnosis of <em>C. difficile</em> infection, though they can be helpful in determining disease severity (the severity scoring system used for adults relies upon laboratory findings [<a href="#rid63">63</a>], but this scoring system has not been validated for children).</p><p>Laboratory findings suggestive of severe or fulminant disease in adults include elevated white blood cell (WBC) count (&gt;15,000 WBCs/microL) or elevated age-adjusted serum creatinine level [<a href="#rid63">63,70</a>]. Individuals with severe disease may also have lactic acidosis or serum albumin level &lt;2.5 g/dL (25 g/L). Although leukocytosis has been reported to be an early marker of <em>C. difficile</em> infection in adults, preceding the onset of diarrhea by one to two days [<a href="#rid48">48,49</a>], leukocytosis does not predict <em>C. difficile</em> test positivity [<a href="#rid71">71</a>].</p><p>In various case series, blood in the stool (gross visible blood or stool guaiac test positive) has been found in 10 to 25 percent of children with <em>C. difficile</em> infection [<a href="#rid32">32-34</a>]; fecal leukocytes can also be present [<a href="#rid33">33,72,73</a>].</p><p class="headingAnchor" id="H14"><span class="h1">RADIOGRAPHIC FEATURES</span><span class="headingEndMark"> — </span>Imaging studies are not necessary for the diagnosis of <em>C. difficile</em> infection, but they may provide the first indication of a complication related to severe disease.</p><p>Abnormal radiographic changes are uncommon in children with mild disease. For children with moderate to severe disease or complications from <em>C. difficile</em> infection, the following radiographic features may be seen on abdominal imaging (computed tomography, plain film, or ultrasonography) [<a href="#rid72">72,74-76</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Thickened colon wall (<a class="graphic graphic_diagnosticimage graphicRef52929 graphicRef52523 graphicRef57812" href="/z/d/graphic/52929.html" rel="external">image 1A-C</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>"Accordion sign" created by contrast or gas trapped between swollen haustra (characteristic but not pathognomonic)</p><p class="bulletIndent1"><span class="glyph">●</span>Wall nodularity</p><p class="bulletIndent1"><span class="glyph">●</span>Pericolonic stranding</p><p class="bulletIndent1"><span class="glyph">●</span>Ascites</p><p class="bulletIndent1"><span class="glyph">●</span>Dilated colon in patients with paralytic ileus or toxic megacolon (<a class="graphic graphic_diagnosticimage graphicRef59217" href="/z/d/graphic/59217.html" rel="external">image 2</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Free air (in patients with colonic perforation)</p><p></p><p class="headingAnchor" id="H2444664466"><span class="h1">APPROACH TO DIAGNOSIS</span><span class="headingEndMark"> — </span>The approach to diagnosis presented below is largely compatible with the recommendations of the American Academy of Pediatrics Committee on Infectious Diseases (2021) [<a href="#rid77">77</a>], the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.idsociety.org%2Fpractice-guideline%2Fclostridium-difficile%2F&amp;token=FtdgY9LPBjngqfa3%2FrNgHlj%2BDpae1o%2F4xMzNDH6KNvsSNskRppha1ovBvqTMkoOpBuoHdPjNMBOmr5QVgNWOSlJvxWnn5%2FQ7hA0pZxgGW2o%3D&amp;TOPIC_ID=6048" target="_blank">Infectious Diseases Society of America and Society for Healthcare Epidemiology of America</a> (2017) [<a href="#rid63">63</a>], and <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fgi.org%2Fguidelines%2F&amp;token=Og4ss9xZ8giAwuAeSJ0YNc6skx84OvXZrMgtpdmNxqc7PB%2F4DeCjmena7knDpUfp&amp;TOPIC_ID=6048" target="_blank">the American College of Gastroenterology</a> (2021) [<a href="#rid78">78</a>].</p><p class="headingAnchor" id="H2444668112"><span class="h2">Clinical evaluation</span><span class="headingEndMark"> — </span>The evaluation is centered on identifying clinical and laboratory findings suggestive of <em>C. difficile </em>infection and differentiating <em>C. difficile</em> infection from other causes of acute-onset diarrhea in children.</p><p>Although it is difficult to distinguish diarrhea due to <em>C. difficile</em> infection from more common causes of diarrhea in children (ie, norovirus, rotavirus) solely based on symptoms, certain clinical and laboratory features increase the likelihood that <em>C. difficile</em> is a causative pathogen (<a class="graphic graphic_table graphicRef71790" href="/z/d/graphic/71790.html" rel="external">table 2</a>) [<a href="#rid72">72,77,79</a>].</p><p>The most common symptom of <em>C. difficile</em> infection is acute-onset watery diarrhea (defined as ≥3 loose bowel movements per day), often occurring during or shortly after a course of antibiotics. Profuse diarrhea (≥10 loose bowel movements per day) and lower abdominal pain and tenderness can occur with pseudomembranous colitis. Fever may be present. If nausea and vomiting are a significant component of the gastrointestinal symptoms, viral etiologies should be considered.</p><p>Children with severe or fulminant disease may have leukocytosis (&gt;15,000 white blood cells/microL), elevated age-adjusted creatinine, hypoalbuminemia (&lt;2.5 g/dL [25 g/L]), or lactic acidosis. Children with severe <em>C. difficile</em> infection can have a rapid reduction of stool output associated with worsening abdominal pain and distention. In such patients, abdominal imaging may be warranted to assess for the development of an ileus or toxic megacolon [<a href="#rid48">48,80</a>]. (See <a class="local">'Radiographic features'</a> above.)</p><p>The following risk factors and predisposing conditions should lower the threshold for consideration of <em>C. difficile</em> infection in children with acute-onset watery diarrhea<em> </em>(see  <a class="medical medical_review" href="/z/d/html/6041.html" rel="external">"<i>Clostridioides difficile</i> infection in children: Microbiology, pathogenesis, and epidemiology", section on 'Risk factors'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Antibiotic exposure</p><p class="bulletIndent1"><span class="glyph">●</span>Gastric acid suppressants</p><p class="bulletIndent1"><span class="glyph">●</span>Gastrointestinal feeding device (eg, gastrostomy or jejunostomy tube)</p><p class="bulletIndent1"><span class="glyph">●</span>Predisposing conditions</p><p class="bulletIndent1"><span class="glyph">●</span>Malignancy</p><p class="bulletIndent1"><span class="glyph">●</span>Hematopoietic cell or solid organ transplantation</p><p class="bulletIndent1"><span class="glyph">●</span>Inflammatory bowel disease</p><p class="bulletIndent1"><span class="glyph">●</span>Cystic fibrosis</p><p class="bulletIndent1"><span class="glyph">●</span>Hirschsprung disease</p><p class="bulletIndent1"><span class="glyph">●</span>Immunodeficiency</p><p class="bulletIndent1"><span class="glyph">●</span>Structural or postoperative intestinal disorders</p><p></p><p class="headingAnchor" id="H337938835"><span class="h2">Indications for testing</span><span class="headingEndMark"> — </span>Testing for <em>C. difficile</em> should only be performed in symptomatic children with clinically significant diarrhea (≥3 loose bowel movements per day or an acute worsening in those with chronic diarrhea) who have clinical features suggestive of <em>C. difficile</em> disease or predisposing conditions (<a class="graphic graphic_table graphicRef71790" href="/z/d/graphic/71790.html" rel="external">table 2</a>). Testing for <em>C. difficile</em> should not be performed in children who have received laxatives in the previous 48 hours [<a href="#rid63">63,81</a>].</p><p>Given the high rate of <em>C. difficile</em> colonization in early life, we provide the following age- and setting-dependent suggestions for testing:</p><p class="bulletIndent1"><span class="glyph">●</span>Infants &lt;12 months of age who are not hospitalized in the neonatal intensive care unit (NICU) – Limit testing to those with Hirschsprung disease or other intestinal motility disorders.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infants &lt;12 months of age hospitalized in the NICU – Testing for <em>C. difficile</em> in infants &lt;12 months of age who are hospitalized in the neonatal intensive care unit (NICU) should be limited to those with [<a href="#rid82">82</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evidence of pseudomembranous colitis</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Clinically significant diarrhea after other causes of infectious (eg, norovirus, rotavirus, adenovirus, enterovirus) and noninfectious diarrhea (eg, opioid withdrawal, malabsorption, feeding intolerance, milk protein allergy) have been excluded (see  <a class="medical medical_review" href="/z/d/html/117487.html" rel="external">"Approach to chronic diarrhea in neonates and young infants (&lt;6 months)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children 1 to 3 years of age – Limit testing to those in whom other causes of diarrhea have been excluded or there is a high suspicion for <em>C. difficile</em> infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children ≥3 years of age – Limit testing to those with clinical features compatible with <em>C. difficile</em> infection who have accompanying risk factors or predisposing conditions. (See <a class="local">'Clinical evaluation'</a> above.)</p><p></p><p>Indiscriminate testing of all children with diarrhea for <em>C. difficile</em> infection can lead to misdiagnosis and unnecessary antibiotic treatment – especially when nucleic acid amplification tests (NAATs) are used in low-risk, young children with community-onset diarrhea [<a href="#rid83">83,84</a>].</p><p class="headingAnchor" id="H1724715877"><span class="h2">Testing for C. difficile</span><span class="headingEndMark"> — </span>Laboratory testing for <em>C. difficile</em> infection involves detection of <em>C. difficile</em> toxin(s) or toxin gene(s) in a stool specimen [<a href="#rid63">63,77</a>]. The available assays cannot distinguish between colonization and infection.</p><p>Testing should only be performed on loose, watery, or semiformed stool specimens (ie, stool that takes the shape of the container) unless ileus or toxic megacolon is suspected [<a href="#rid63">63,77,85</a>]. Many laboratories do not perform routine testing of samples from children &lt;12 months of age. For patients with suspected <em>C. difficile</em> infection and ileus, a perirectal swab may be necessary [<a href="#rid86">86</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Testing approach</strong> – When testing for <em>C. difficile</em>, we suggest either a NAAT assay alone or a multistep algorithm consisting of initial enzyme immunoassay (EIA) screening for glutamate dehydrogenase (GDH) antigen and toxins A and B, followed by NAAT if EIA assays are discordant (<a class="graphic graphic_algorithm graphicRef100540" href="/z/d/graphic/100540.html" rel="external">algorithm 1</a>) [<a href="#rid63">63,87-89</a>]; the multistep algorithm is preferred for neonates in the NICU [<a href="#rid82">82</a>], when indicated (see <a class="local">'Indications for testing'</a> above). Other approaches that include a highly sensitive and a highly specific testing modality are reasonable [<a href="#rid63">63,78</a>]. As an example, the American College of Gastroenterology suggests initial testing with the highly specific NAAT or GDH EIA, followed by the highly specific EIA for toxins A and B if initial testing is positive [<a href="#rid78">78</a>].</p><p></p><p class="bulletIndent1">The high sensitivity and specificity of the NAAT assays, together with their rapid turnaround time, allow for prompt isolation and treatment of patients with <em>C. difficile</em> infection. This decreases the opportunity for health care-associated spread and may improve patient outcomes. The multistep algorithm is a less expensive option but takes slightly longer compared with NAAT alone.</p><p></p><p class="bulletIndent1">In children with moderate to severe diarrhea with negative results on <em>C. difficile</em> testing, detailed evaluation for other causes of diarrhea (including underlying gastrointestinal disorders) is warranted. Repeat NAAT testing of stool should not be performed for at least seven days [<a href="#rid63">63,89,90</a>]. (See <a class="local">'Differential diagnosis'</a> below and <a class="local">'Radiographic features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stool tests</strong> – Several diagnostic tests are available that detect <em>C. difficile</em> toxin(s), toxin gene(s), or toxigenic <em>C. difficile</em> organisms, in decreasing order of sensitivity (<a class="graphic graphic_table graphicRef100666" href="/z/d/graphic/100666.html" rel="external">table 3</a>) [<a href="#rid63">63,77</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Toxigenic culture</strong> – The reference standard method of detecting toxigenic <em>C. difficile</em> organisms in stool specimens is the toxigenic culture [<a href="#rid91">91</a>]. It is performed by isolating <em>C. difficile</em> on selective culture media with subsequent toxin testing of the isolated colonies [<a href="#rid91">91</a>]. This method is limited by slow turnaround and need for technical expertise; it is rarely employed as a routine diagnostic test.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>NAATs</strong> – NAATs, including real-time polymerase chain reaction (PCR) and loop-mediated isothermal amplification, detect the genes that encode toxin A and/or B (<em>tcdA</em> and <em>tcdB</em>). NAATs are sensitive (95 percent) and specific (&gt;97 percent) in detecting the presence of toxin-producing <em>C. difficile</em> organisms; however, they do not distinguish colonization from clinical infection [<a href="#rid63">63,92</a>]. Test results are rapidly available, permitting prompt isolation and treatment of patients with <em>C. difficile</em> infection. However, NAATs are expensive. They also may lead to identification of incidental <em>C. difficile</em> carriers because of their high sensitivity.</p><p></p><p class="bulletIndent2">Multiplex PCR panels can test for multiple gastrointestinal pathogens simultaneously [<a href="#rid93">93</a>]; when applied to children with acute diarrhe<em>a, C. difficile</em> coinfection with other enteric pathogens may be detected [<a href="#rid26">26,94,95</a>]. To avoid overdiagnosis and overtreatment of <em>C. difficile</em> infection, multiplex panels that include<em> C. difficile</em> must be interpreted with caution, particularly when obtained in children at low risk for<em> C. difficile</em> infection, in whom detection of<em> C. difficile</em> likely represents colonization [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>EIA for </strong><strong><em>C. difficile</em></strong><strong> GDH</strong> – GDH is an enzyme produced by all strains of <em>C. difficile</em>. Since GDH antigen testing cannot distinguish between toxigenic and nontoxigenic strains, it is only useful as an initial screening test in a multistep algorithm [<a href="#rid91">91,96</a>], where positive samples undergo additional testing (ie, EIA for toxin or NAAT for toxigenic organism) and negative samples are finalized and reported. GDH antigen testing is highly sensitive and has a rapid turnaround time. Two-step algorithms combining an initial GDH assay followed by NAAT assay are sensitive, economical, and permit rapid reporting of negative results [<a href="#rid91">91,97-99</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cell culture cytotoxicity assay</strong> – The reference standard of detecting <em>C. difficile</em> toxins A and/or B in stool specimens has been the cell culture cytotoxicity assay. It is performed by placing a filtered stool suspension onto cell culture. If <em>C. difficile</em> toxin is present, a characteristic cytopathic effect will be noted after 24 to 48 hours [<a href="#rid91">91</a>]. The cell culture cytotoxicity assay has a high sensitivity and specificity and the strongest correlation with clinical outcomes [<a href="#rid100">100</a>]. However, it is labor intensive and requires technical expertise; it is rarely employed as a routine diagnostic test.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>EIA for toxin A and/or B</strong> – Stool EIA for toxin A and/or B is widely used for the diagnosis of <em>C. difficile</em> infection. These tests are inexpensive and provide results within hours. Their major limitation is poor sensitivity (70 percent, 95% CI 66-74) [<a href="#rid63">63,92</a>]. Repeat testing after an initial negative EIA test has little clinical utility [<a href="#rid101">101</a>]. In addition, colonized children can have a positive toxin test, so EIA may not fully differentiate between colonization and symptomatic <em>C. difficile</em> infection [<a href="#rid31">31,102</a>].</p><p></p><p class="headingAnchor" id="H2444665699"><span class="h2">Endoscopy</span><span class="headingEndMark"> — </span>Endoscopy is rarely needed to diagnose <em>C. difficile</em> infection. However, it may be warranted when an alternative diagnosis is suspected and visualization and/or biopsy of the intestinal mucosa is required. In such cases, sigmoidoscopy or colonoscopy may demonstrate pseudomembranous colitis and can provide fresh luminal content for <em>C. difficile</em> testing.</p><p>Pseudomembranous colitis is strongly supported by the observation of 2 to 5 mm yellowish plaques (<a class="graphic graphic_picture graphicRef53774 graphicRef62422" href="/z/d/graphic/53774.html" rel="external">picture 1A-B</a>). Findings of typical pseudomembranous colitis usually are absent in flares of IBD associated with <em>C. difficile</em> infection.</p><p class="headingAnchor" id="H2444665894"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of <em>C. difficile</em> infection is based on a combination of clinical and laboratory findings (<a class="graphic graphic_table graphicRef71790" href="/z/d/graphic/71790.html" rel="external">table 2</a>): clinically significant diarrhea (≥3 loose bowel movements per day) or ileus with a positive <em>C. difficile</em> test. The finding of pseudomembranous colitis (by endoscopy or histology) is suggestive of <em>C. difficile</em> infection and should prompt testing [<a href="#rid63">63,77,79</a>].</p><p>The diagnosis of <em>C. difficile</em> infection in children can be challenging. Validated clinical criteria that reliably distinguish between <em>C. difficile</em> colonization (where a positive stool assay is an incidental finding) and infection do not exist, nor is there a stool test or testing algorithm that can differentiate between colonization and infection. However, identifying clinical features suggestive of <em>C. difficile</em> makes it more likely that <em>C. difficile</em> infection is present in a child with a positive stool test. (See <a class="local">'Symptomatic disease'</a> above.)</p><p class="headingAnchor" id="H2444666133"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of <em>C. difficile</em> infection in children depends upon the clinical setting [<a href="#rid103">103,104</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonbloody diarrhea</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Viral enteritis – Mild <em>C. difficile</em> infection may be indistinguishable from diarrhea due to enteric viruses such as norovirus, rotavirus, and many others. In infants and young children, mild, self-limited diarrhea is most likely to be viral. Testing for viral pathogens may be helpful in establishing a diagnosis of viral diarrhea, but generally is not necessary. (See  <a class="medical medical_review" href="/z/d/html/6456.html" rel="external">"Diagnostic approach to diarrhea in children in resource-abundant settings"</a> and  <a class="medical medical_review" href="/z/d/html/2681.html" rel="external">"Clinical manifestations and diagnosis of rotavirus infection", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Parasitic infection – Intestinal parasites, such as <em>Giardia intestinalis</em>, <em>Cryptosporidium</em>, and others, may cause relatively prolonged watery diarrhea. Parasites generally are diagnosed with stool microscopy or antigen-based assays. (See  <a class="medical medical_review" href="/z/d/html/5733.html" rel="external">"Cryptosporidiosis: Epidemiology, clinical manifestations, and diagnosis", section on 'Microscopy'</a> and  <a class="medical medical_review" href="/z/d/html/5723.html" rel="external">"Giardiasis: Epidemiology, clinical manifestations, and diagnosis", section on 'Stool microscopy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bloody diarrhea</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bacterial infection – <em>Salmonella</em>, <em>Shigella</em>, <em>Yersinia</em>, <em>Campylobacter</em>, and toxigenic or invasive <em>Escherichia coli</em> may present with fever, inflammatory and/or bloody diarrhea, or laboratory signs of inflammation (eg, leukocytosis). Testing for bacterial etiologies may be warranted for children with community-acquired diarrhea. However, bacteria other than <em>C. difficile</em> rarely cause hospital-onset diarrhea [<a href="#rid105">105</a>]. (See  <a class="medical medical_review" href="/z/d/html/2718.html" rel="external">"Shigella infection: Epidemiology, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/2714.html" rel="external">"Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Noninfectious inflammatory or bloody diarrhea – Noninfectious causes of bloody diarrhea include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Inflammatory bowel disease (see  <a class="medical medical_review" href="/z/d/html/5879.html" rel="external">"Clinical presentation and diagnosis of inflammatory bowel disease in children"</a>)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Neonatal necrotizing enterocolitis, which has not been associated with <em>C. difficile</em>, even though heavy colonization is common in this age group</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Gastrointestinal mucositis in patients receiving chemotherapy or radiation therapy</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pseudomembranous colitis</strong> – Cases of pseudomembranous colitis, in the absence of <em>C. difficile</em> infection, have been attributed to rotavirus, adenovirus, <em>E. coli</em> O157, <em>Salmonella</em>, <em>Shigella</em>, and antibiotic-induced <em>Staphylococcus aureus</em> enterocolitis [<a href="#rid106">106-110</a>]. (See  <a class="medical medical_review" href="/z/d/html/2718.html" rel="external">"Shigella infection: Epidemiology, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/2681.html" rel="external">"Clinical manifestations and diagnosis of rotavirus infection", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/2714.html" rel="external">"Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fulminant colitis</strong> – Fulminant colitis must be differentiated from other causes of acute intra-abdominal disease (eg, appendicitis, intussusception, inflammatory bowel disease) [<a href="#rid103">103</a>]. (See  <a class="medical medical_review" href="/z/d/html/6454.html" rel="external">"Causes of acute abdominal pain in children and adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/6434.html" rel="external">"Emergency evaluation of the child with acute abdominal pain"</a>.)</p><p></p><p class="headingAnchor" id="H2906173495"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/110248.html" rel="external">"Society guideline links: <i>Clostridioides difficile</i> infection"</a>.)</p><p class="headingAnchor" id="H15"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical and laboratory features</strong> – The clinical spectrum of <em>Clostridioides</em> <em>difficile</em> infection ranges from asymptomatic colonization to fulminant colitis. The full spectrum of disease is possible in children. (See <a class="local">'Clinical spectrum'</a> above.)</p><p></p><p class="bulletIndent1">Symptoms of <em>C. difficile</em> infection typically begin either during or within a few weeks after antibiotic therapy. Mild to moderate diarrhea is the most common presentation of symptomatic <em>C. difficile</em> infection. The diarrhea is usually watery and may be accompanied by fever, lower abdominal cramping, and other systemic signs. The physical examination is typically normal or may demonstrate lower abdominal tenderness. (See <a class="local">'Diarrhea'</a> above.)</p><p></p><p class="bulletIndent1">Laboratory findings that suggest severe or fulminant <em>C. difficile</em> infection include elevated white blood cell count (&gt;15,000 cells/microL) or elevated age-adjusted serum creatinine level. (See <a class="local">'Laboratory features'</a> above.)</p><p></p><p class="bulletIndent1">Certain patient characteristics and clinical features are more indicative that gastrointestinal symptoms in a given patient are due to <em>C. difficile</em> infection (<a class="graphic graphic_table graphicRef71790" href="/z/d/graphic/71790.html" rel="external">table 2</a>). In the absence of these factors, <em>C. difficile</em> is less likely than other causes of diarrhea. (See <a class="local">'Approach to diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications for testing</strong> – Testing for <em>C. difficile</em> should only be performed in symptomatic children with clinically significant diarrhea (≥3 loose bowel movements per day) who have clinical features suggestive of <em>C. difficile</em> infection or predisposing conditions (<a class="graphic graphic_table graphicRef71790" href="/z/d/graphic/71790.html" rel="external">table 2</a>). (See <a class="local">'Indications for testing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Approach to testing</strong> – A number of stool tests are available for <em>C. difficile</em> infection (<a class="graphic graphic_table graphicRef100666" href="/z/d/graphic/100666.html" rel="external">table 3</a>).</p><p></p><p class="bulletIndent1">We suggest either a nucleic acid amplification test (NAAT) assay or a multistep algorithm consisting of a glutamate dehydrogenase (GDH) antigen assay combined with a toxin assay, followed by NAAT testing if the results are discordant (<a class="graphic graphic_algorithm graphicRef100540" href="/z/d/graphic/100540.html" rel="external">algorithm 1</a>). Testing should only be performed on loose, watery, or semiformed stool specimens and is rarely indicated in children &lt;12 months of age. (See <a class="local">'Testing for C. difficile'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis </strong>– The diagnosis of <em>C. difficile</em> infection in children is based on a combination of clinical and laboratory findings: clinically significant diarrhea (acute change in stooling habits and ≥3 loose bowel movements per day) or ileus with a positive <em>C. difficile</em> diagnostic test. Findings of pseudomembranous colitis (by endoscopy or histology) suggest <em>C. difficile</em> infection and should prompt further testing. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The possibility that <em>C. difficile</em> is an incidental finding, particularly in infants and young children, must be considered. Even if such children have positive tests for toxigenic <em>C. difficile</em>, alternative causes of diarrhea (viral, parasitic, and other bacteria) often are more likely and treatment for<em> C. difficile </em>may not be indicated. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="headingAnchor" id="H16"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Michael Cooperstock, MD, MPH, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015; 372:825.</a></li><li><a class="nounderline abstract_t">Kim J, Smathers SA, Prasad P, et al. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008; 122:1266.</a></li><li><a class="nounderline abstract_t">Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010; 16:604.</a></li><li><a class="nounderline abstract_t">Nylund CM, Goudie A, Garza JM, et al. Clostridium difficile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med 2011; 165:451.</a></li><li><a class="nounderline abstract_t">Deshpande A, Pant C, Anderson MP, et al. Clostridium difficile infection in the hospitalized pediatric population: increasing trend in disease incidence. Pediatr Infect Dis J 2013; 32:1138.</a></li><li><a class="nounderline abstract_t">Bryant K, McDonald LC. Clostridium difficile infections in children. Pediatr Infect Dis J 2009; 28:145.</a></li><li><a class="nounderline abstract_t">Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med 2015; 372:1539.</a></li><li><a class="nounderline abstract_t">Pai S, Aliyu SH, Enoch DA, Karas JA. Five years experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management. PLoS One 2012; 7:e51728.</a></li><li><a class="nounderline abstract_t">Schwartz KL, Darwish I, Richardson SE, et al. Severe clinical outcome is uncommon in Clostridium difficile infection in children: a retrospective cohort study. BMC Pediatr 2014; 14:28.</a></li><li><a class="nounderline abstract_t">Viscidi RP, Bartlett JG. Antibiotic-associated pseudomembranous colitis in children. Pediatrics 1981; 67:381.</a></li><li><a class="nounderline abstract_t">Wendt JM, Cohen JA, Mu Y, et al. Clostridium difficile infection among children across diverse US geographic locations. Pediatrics 2014; 133:651.</a></li><li><a class="nounderline abstract_t">Rousseau C, Poilane I, De Pontual L, et al. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis 2012; 55:1209.</a></li><li><a class="nounderline abstract_t">Caroff DA, Yokoe DS, Klompas M. Evolving Insights Into the Epidemiology and Control of Clostridium difficile in Hospitals. Clin Infect Dis 2017; 65:1232.</a></li><li><a class="nounderline abstract_t">Enoch DA, Butler MJ, Pai S, et al. Clostridium difficile in children: colonisation and disease. J Infect 2011; 63:105.</a></li><li><a class="nounderline abstract_t">Tougas SR, Lodha N, Vandermeer B, et al. Prevalence of Detection of Clostridioides difficile Among Asymptomatic Children: A Systematic Review and Meta-analysis. JAMA Pediatr 2021; 175:e212328.</a></li><li><a class="nounderline abstract_t">Cerquetti M, Luzzi I, Caprioli A, et al. Role of Clostridium difficile in childhood diarrhea. Pediatr Infect Dis J 1995; 14:598.</a></li><li><a class="nounderline abstract_t">Vernacchio L, Vezina RM, Mitchell AA, et al. Diarrhea in American infants and young children in the community setting: incidence, clinical presentation and microbiology. Pediatr Infect Dis J 2006; 25:2.</a></li><li><a class="nounderline abstract_t">Ellis ME, Mandal BK, Dunbar EM, Bundell KR. Clostridium difficile and its cytotoxin in infants admitted to hospital with infectious gastroenteritis. Br Med J (Clin Res Ed) 1984; 288:524.</a></li><li><a class="nounderline abstract_t">Kotloff KL, Wade JC, Morris JG Jr. Lack of association between Clostridium difficile toxin and diarrhea in infants. Pediatr Infect Dis J 1988; 7:662.</a></li><li><a class="nounderline abstract_t">Tang P, Roscoe M, Richardson SE. Limited clinical utility of Clostridium difficile toxin testing in infants in a pediatric hospital. Diagn Microbiol Infect Dis 2005; 52:91.</a></li><li><a class="nounderline abstract_t">Mårdh PA, Helin I, Colleen I, et al. Clostridium difficile toxin in faecal specimens of healthy children and children with diarrhoea. Acta Paediatr Scand 1982; 71:275.</a></li><li><a class="nounderline abstract_t">Svedhem A, Kaijser B, MacDowall I. Intestinal occurrence of Campylobacter fetus subspecies jejuni and Clostridium difficile in children in Sweden. Eur J Clin Microbiol 1982; 1:29.</a></li><li><a class="nounderline abstract_t">González-Del Vecchio M, Álvarez-Uria A, Marin M, et al. Clinical Significance of Clostridium difficile in Children Less Than 2 Years Old: A Case-Control Study. Pediatr Infect Dis J 2016; 35:281.</a></li><li><a class="nounderline abstract_t">Klein EJ, Boster DR, Stapp JR, et al. Diarrhea etiology in a Children's Hospital Emergency Department: a prospective cohort study. Clin Infect Dis 2006; 43:807.</a></li><li><a class="nounderline abstract_t">de Graaf H, Pai S, Burns DA, et al. Co-infection as a confounder for the role of Clostridium difficile infection in children with diarrhoea: a summary of the literature. Eur J Clin Microbiol Infect Dis 2015; 34:1281.</a></li><li><a class="nounderline abstract_t">Cotter JM, Thomas J, Birkholz M, et al. Impact of Multiplex Testing on the Identification of Pediatric Clostridiodes Difficile. J Pediatr 2020; 218:157.</a></li><li><a class="nounderline abstract_t">Leibowitz J, Soma VL, Rosen L, et al. Similar proportions of stool specimens from hospitalized children with and without diarrhea test positive for Clostridium difficile. Pediatr Infect Dis J 2015; 34:261.</a></li><li><a class="nounderline abstract_t">Dominguez SR, Dolan SA, West K, et al. High colonization rate and prolonged shedding of Clostridium difficile in pediatric oncology patients. Clin Infect Dis 2014; 59:401.</a></li><li><a class="nounderline abstract_t">Theunissen C, Knoop C, Nonhoff C, et al. Clostridium difficile colitis in cystic fibrosis patients with and without lung transplantation. Transpl Infect Dis 2008; 10:240.</a></li><li><a class="nounderline abstract_t">Hourigan SK, Sears CL, Oliva-Hemker M. Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2016; 22:1020.</a></li><li><a class="nounderline abstract_t">Parnell JM, Fazili I, Bloch SC, et al. Two-step Testing for Clostridioides Difficile is Inadequate in Differentiating Infection From Colonization in Children. J Pediatr Gastroenterol Nutr 2021; 72:378.</a></li><li><a class="nounderline abstract_t">Morinville V, McDonald J. Clostridium difficile-associated diarrhea in 200 Canadian children. Can J Gastroenterol 2005; 19:497.</a></li><li><a class="nounderline abstract_t">Gogate A, De A, Nanivadekar R, et al. Diagnostic role of stool culture &amp; toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children. Indian J Med Res 2005; 122:518.</a></li><li><a class="nounderline abstract_t">Crews JD, Koo HL, Jiang ZD, et al. A hospital-based study of the clinical characteristics of Clostridium difficile infection in children. Pediatr Infect Dis J 2014; 33:924.</a></li><li><a class="nounderline abstract_t">Nicholson MR, Thomsen IP, Slaughter JC, et al. Novel risk factors for recurrent Clostridium difficile infection in children. J Pediatr Gastroenterol Nutr 2015; 60:18.</a></li><li><a class="nounderline abstract_t">Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330:257.</a></li><li><a class="nounderline abstract_t">Zwiener RJ, Belknap WM, Quan R. Severe pseudomembranous enterocolitis in a child: case report and literature review. Pediatr Infect Dis J 1989; 8:876.</a></li><li><a class="nounderline abstract_t">Harris PR, Figueroa-Colon R. Rectal prolapse in children associated with Clostridium difficile infection. Pediatr Infect Dis J 1995; 14:78.</a></li><li><a class="nounderline abstract_t">Park JH, Chung MH, Kim JY, et al. Intussusception associated with pseudomembranous colitis. J Pediatr Gastroenterol Nutr 2008; 46:470.</a></li><li><a class="nounderline abstract_t">Fitzgerald J, Troncone R, Cole CR, Kaul A. Clinical quiz. An ileocolonic intussusception associated with C. difficile infection. J Pediatr Gastroenterol Nutr 2001; 33:289, 300.</a></li><li><a class="nounderline abstract_t">Gillett PM, Russell RK, Wilson DC, Thomas AE. C difficile induced pneumatosis intestinalis in a neutropenic child. Arch Dis Child 2002; 87:85.</a></li><li><a class="nounderline abstract_t">Burton EM, Mercado-Deane MG, Patel K. Pneumatosis intestinalis in a child with AIDS and pseudomembranous colitis. Pediatr Radiol 1994; 24:609.</a></li><li><a class="nounderline abstract_t">Adler SP, Chandrika T, Berman WF. Clostridium difficile associated with pseudomembranous colitis. Occurrence in a 12-week-old infant without prior antibiotic therapy. Am J Dis Child 1981; 135:820.</a></li><li><a class="nounderline abstract_t">Richardson SA, Brookfield DS, French TA, Gray J. Pseudomembranous colitis in a 5-week-old infant. Br Med J (Clin Res Ed) 1981; 283:1510.</a></li><li><a class="nounderline abstract_t">Singer DB, Cashore WJ, Widness JA, et al. Pseudomembranous colitis in a preterm neonate. J Pediatr Gastroenterol Nutr 1986; 5:318.</a></li><li><a class="nounderline abstract_t">Harmon T, Burkhart G, Applebaum H. Perforated pseudomembranous colitis in the breast-fed infant. J Pediatr Surg 1992; 27:744.</a></li><li><a class="nounderline abstract_t">Mandal BK, Watson B, Ellis M. Pseudomembranous colitis in a 5-week-old infant. Br Med J (Clin Res Ed) 1982; 284:345.</a></li><li><a class="nounderline abstract_t">Bulusu M, Narayan S, Shetler K, Triadafilopoulos G. Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea. Am J Gastroenterol 2000; 95:3137.</a></li><li><a class="nounderline abstract_t">Wanahita A, Goldsmith EA, Marino BJ, Musher DM. Clostridium difficile infection in patients with unexplained leukocytosis. Am J Med 2003; 115:543.</a></li><li><a class="nounderline abstract_t">Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum 1995; 38:350.</a></li><li><a class="nounderline abstract_t">Lamontagne F, Labbé AC, Haeck O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg 2007; 245:267.</a></li><li><a class="nounderline abstract_t">Jacobs A, Barnard K, Fishel R, Gradon JD. Extracolonic manifestations of Clostridium difficile infections. Presentation of 2 cases and review of the literature. Medicine (Baltimore) 2001; 80:88.</a></li><li><a class="nounderline abstract_t">Gupta A, Patel R, Baddour LM, et al. Extraintestinal Clostridium difficile infections: a single-center experience. Mayo Clin Proc 2014; 89:1525.</a></li><li><a class="nounderline abstract_t">Gaglani MJ, Murray JC, Morad AB, Edwards MS. Chronic osteomyelitis caused by Clostridium difficile in an adolescent with sickle cell disease. Pediatr Infect Dis J 1996; 15:1054.</a></li><li><a class="nounderline abstract_t">Cron RQ, Gordon PV. Reactive arthritis to Clostridium difficile in a child. West J Med 1997; 166:419.</a></li><li><a class="nounderline abstract_t">Durand CL, Miller PF. Severe Clostridium difficile colitis and reactive arthritis in a ten-year-old child. Pediatr Infect Dis J 2009; 28:750.</a></li><li><a class="nounderline abstract_t">Löffler HA, Pron B, Mouy R, et al. Clostridium difficile-associated reactive arthritis in two children. Joint Bone Spine 2004; 71:60.</a></li><li><a class="nounderline abstract_t">Horton DB, Strom BL, Putt ME, et al. Epidemiology of Clostridium difficile Infection-Associated Reactive Arthritis in Children: An Underdiagnosed, Potentially Morbid Condition. JAMA Pediatr 2016; 170:e160217.</a></li><li><a class="nounderline abstract_t">Khanna S, Baddour LM, Huskins WC, et al. The epidemiology of Clostridium difficile infection in children: a population-based study. Clin Infect Dis 2013; 56:1401.</a></li><li><a class="nounderline abstract_t">Nicholson MR, Crews JD, Starke JR, et al. Recurrent Clostridium difficile Infection in Children: Patient Risk Factors and Markers of Intestinal Inflammation. Pediatr Infect Dis J 2017; 36:379.</a></li><li><a class="nounderline abstract_t">Aldrich AM, Argo T, Koehler TJ, Olivero R. Analysis of Treatment Outcomes for Recurrent Clostridium difficile Infections and Fecal Microbiota Transplantation in a Pediatric Hospital. Pediatr Infect Dis J 2019; 38:32.</a></li><li><a class="nounderline abstract_t">Pépin J, Routhier S, Gagnon S, Brazeau I. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis 2006; 42:758.</a></li><li><a class="nounderline abstract_t">McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018; 66:e1.</a></li><li><a class="nounderline abstract_t">McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28:140.</a></li><li><a class="nounderline abstract_t">Kamboj M, Khosa P, Kaltsas A, et al. Relapse versus reinfection: surveillance of Clostridium difficile infection. Clin Infect Dis 2011; 53:1003.</a></li><li><a class="nounderline abstract_t">Kyne L, Warny M, Qamar A, Kelly CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001; 357:189.</a></li><li><a class="nounderline abstract_t">Garey KW, Jiang ZD, Ghantoji S, et al. A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection. Clin Infect Dis 2010; 51:1406.</a></li><li><a class="nounderline abstract_t">Tschudin-Sutter S, Tamma PD, Milstone AM, Perl TM. Predictors of first recurrence of Clostridium difficile infections in children. Pediatr Infect Dis J 2014; 33:414.</a></li><li><a class="nounderline abstract_t">Kociolek LK, Palac HL, Patel SJ, et al. Risk Factors for Recurrent Clostridium difficile Infection in Children: A Nested Case-Control Study. J Pediatr 2015; 167:384.</a></li><li><a class="nounderline abstract_t">Tamma PD, Sandora TJ. Clostridium difficile Infection in Children: Current State and Unanswered Questions. J Pediatric Infect Dis Soc 2012; 1:230.</a></li><li><a class="nounderline abstract_t">Bosch DE, Mathias PC, Krumm N, et al. Elevated White Blood Cell Count Does Not Predict Clostridium difficile Nucleic Acid Testing Results. Clin Infect Dis 2021; 73:699.</a></li><li><a class="nounderline abstract_t">Fekety R, Shah AB. Diagnosis and treatment of Clostridium difficile colitis. JAMA 1993; 269:71.</a></li><li><a class="nounderline abstract_t">Reddymasu S, Sheth A, Banks DE. Is Fecal Leukocyte Test a good predictor of Clostridium difficile associated diarrhea? Ann Clin Microbiol Antimicrob 2006; 5:9.</a></li><li><a class="nounderline abstract_t">Blickman JG, Boland GW, Cleveland RH, et al. Pseudomembranous colitis: CT findings in children. Pediatr Radiol 1995; 25 Suppl 1:S157.</a></li><li><a class="nounderline abstract_t">Razzaq R, Sukumar SA. Ultrasound diagnosis of clinically undetected Clostridium difficile toxin colitis. Clin Radiol 2006; 61:446.</a></li><li><a class="nounderline abstract_t">Kirkpatrick ID, Greenberg HM. Evaluating the CT diagnosis of Clostridium difficile colitis: should CT guide therapy? AJR Am J Roentgenol 2001; 176:635.</a></li><li class="breakAll">American Academy of Pediatrics. Clostridioides difficile (formerly Clostridium difficile). In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.271.</li><li><a class="nounderline abstract_t">Kelly CR, Fischer M, Allegretti JR, et al. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. Am J Gastroenterol 2021; 116:1124.</a></li><li><a class="nounderline abstract_t">Crobach MJ, Planche T, Eckert C, et al. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 2016; 22 Suppl 4:S63.</a></li><li><a class="nounderline abstract_t">Zahariadis G, Connon JJ, Fong IW. Fulminant Clostridium difficile colitis without diarrhea: lack of emphasis in diagnostic guidelines. Am J Gastroenterol 2002; 97:2929.</a></li><li><a class="nounderline abstract_t">Guery B, Galperine T, Barbut F. Clostridioides difficile: diagnosis and treatments. BMJ 2019; 366:l4609.</a></li><li><a class="nounderline abstract_t">Sandora TJ, Bryant KK, Cantey JB, et al. SHEA neonatal intensive care unit (NICU) white paper series: Practical approaches to Clostridioides difficile prevention. Infect Control Hosp Epidemiol 2018; 39:1149.</a></li><li><a class="nounderline abstract_t">Kociolek LK, Patel SJ, Zheng X, et al. Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing Decisions. Pediatr Infect Dis J 2016; 35:157.</a></li><li><a class="nounderline abstract_t">Kociolek LK, Bovee M, Carter D, et al. Impact of a Healthcare Provider Educational Intervention on Frequency of Clostridium difficile Polymerase Chain Reaction Testing in Children: A Segmented Regression Analysis. J Pediatric Infect Dis Soc 2016.</a></li><li><a class="nounderline abstract_t">Katz DA, Lynch ME, Littenberg B. Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea. Am J Med 1996; 100:487.</a></li><li><a class="nounderline abstract_t">Kundrapu S, Sunkesula VC, Jury LA, et al. Utility of perirectal swab specimens for diagnosis of Clostridium difficile infection. Clin Infect Dis 2012; 55:1527.</a></li><li><a class="nounderline abstract_t">Goldenberg SD, Cliff PR, Smith S, et al. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile. J Hosp Infect 2010; 74:48.</a></li><li><a class="nounderline abstract_t">Novak-Weekley SM, Marlowe EM, Miller JM, et al. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol 2010; 48:889.</a></li><li><a class="nounderline abstract_t">Miller JM, Binnicker MJ, Campbell S, et al. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 2018; 67:e1.</a></li><li><a class="nounderline abstract_t">Luo RF, Banaei N. Is repeat PCR needed for diagnosis of Clostridium difficile infection? J Clin Microbiol 2010; 48:3738.</a></li><li><a class="nounderline abstract_t">Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA 2015; 313:398.</a></li><li class="breakAll">Butler M, Olson A, Drekonja D, et al. Early diagnosis, prevention, and treatment of Clostridium difficile: Update. Comparative Effectiveness Review No. 172. Agency for Healthcare Research and Quality, Rockville, MD. March 2016. https://effectivehealthcare.ahrq.gov/reports/final.cfm (Accessed on April 06, 2016).</li><li><a class="nounderline abstract_t">Buss SN, Leber A, Chapin K, et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol 2015; 53:915.</a></li><li><a class="nounderline abstract_t">Nicholson MR, Van Horn GT, Tang YW, et al. Using Multiplex Molecular Testing to Determine the Etiology of Acute Gastroenteritis in Children. J Pediatr 2016; 176:50.</a></li><li><a class="nounderline abstract_t">Stockmann C, Pavia AT, Graham B, et al. Detection of 23 Gastrointestinal Pathogens Among Children Who Present With Diarrhea. J Pediatric Infect Dis Soc 2016.</a></li><li><a class="nounderline abstract_t">Selvaraju SB, Gripka M, Estes K, et al. Detection of toxigenic Clostridium difficile in pediatric stool samples: an evaluation of Quik Check Complete Antigen assay, BD GeneOhm Cdiff PCR, and ProGastro Cd PCR assays. Diagn Microbiol Infect Dis 2011; 71:224.</a></li><li><a class="nounderline abstract_t">Ticehurst JR, Aird DZ, Dam LM, et al. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 2006; 44:1145.</a></li><li><a class="nounderline abstract_t">Reller ME, Lema CA, Perl TM, et al. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol 2007; 45:3601.</a></li><li><a class="nounderline abstract_t">Fenner L, Widmer AF, Goy G, et al. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol 2008; 46:328.</a></li><li><a class="nounderline abstract_t">Planche TD, Davies KA, Coen PG, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis 2013; 13:936.</a></li><li><a class="nounderline abstract_t">Garimella PS, Agarwal R, Katz A. The utility of repeat enzyme immunoassay testing for the diagnosis of Clostridium difficile infection: a systematic review of the literature. J Postgrad Med 2012; 58:194.</a></li><li><a class="nounderline abstract_t">Sandora TJ, Williams DN, Daugherty K, et al. Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age. J Pediatric Infect Dis Soc 2022; 11:454.</a></li><li class="breakAll">Singh N, Klontz K. Clostridium difficile. In: Principles and Practice of Pediatric Infectious Diseases, 5th ed, Long SS, Prober CG, Fischer M (Eds), Elsevier, Philadelphia 2018. p.1006.</li><li class="breakAll">Statler V, Bryant KA. Antibiotic-associated colitis. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 8th ed, Cherry JD, Harrison G, Kaplan SL, et al (Eds), Elsevier, Philadelphia 2018. p.465.</li><li><a class="nounderline abstract_t">Zaidi AK, Macone A, Goldmann AD. Impact of simple screening criteria on utilization of low-yield bacterial stool cultures in a Children's Hospital. Pediatrics 1999; 103:1189.</a></li><li><a class="nounderline abstract_t">Wenzl TG, Kusenbach G, Skopnik H. Pseudomembranous viral colitis. J Pediatr Gastroenterol Nutr 2000; 30:472.</a></li><li><a class="nounderline abstract_t">Uc A, Mitros FA, Kao SC, Sanders KD. Pseudomembranous colitis with Escherichia coli O157:H7. J Pediatr Gastroenterol Nutr 1997; 24:590.</a></li><li><a class="nounderline abstract_t">Beck A, McNeil C, Abdelsayed G, et al. Salmonella pseudomembranous colitis. Conn Med 2007; 71:339.</a></li><li><a class="nounderline abstract_t">Kelber M, Ament ME. Shigella dysenteriae I: a forgotten cause of pseudomembranous colitis. J Pediatr 1976; 89:595.</a></li><li><a class="nounderline abstract_t">Gravet A, Rondeau M, Harf-Monteil C, et al. Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD. J Clin Microbiol 1999; 37:4012.</a></li></ol></div><div id="topicVersionRevision">Topic 6048 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25714160" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Burden of Clostridium difficile infection in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19047244" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20350373" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Clostridium difficile infections among hospitalized children, United States, 1997-2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21199971" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Clostridium difficile infection in hospitalized children in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23546535" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Clostridium difficile infection in the hospitalized pediatric population: increasing trend in disease incidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19174687" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Clostridium difficile infections in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25875259" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Clostridium difficile infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23300561" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Five years experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24485120" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Severe clinical outcome is uncommon in Clostridium difficile infection in children: a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7243476" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Antibiotic-associated pseudomembranous colitis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24590748" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Clostridium difficile infection among children across diverse US geographic locations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22843784" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28520953" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Evolving Insights Into the Epidemiology and Control of Clostridium difficile in Hospitals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21664931" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Clostridium difficile in children: colonisation and disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34338715" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Prevalence of Detection of Clostridioides difficile Among Asymptomatic Children: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7567289" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Role of Clostridium difficile in childhood diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16395094" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Diarrhea in American infants and young children in the community setting: incidence, clinical presentation and microbiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6421363" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clostridium difficile and its cytotoxin in infants admitted to hospital with infectious gastroenteritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3174309" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Lack of association between Clostridium difficile toxin and diarrhea in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15964495" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Limited clinical utility of Clostridium difficile toxin testing in infants in a pediatric hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7136636" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Clostridium difficile toxin in faecal specimens of healthy children and children with diarrhoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7173168" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Intestinal occurrence of Campylobacter fetus subspecies jejuni and Clostridium difficile in children in Sweden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26650114" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Clinical Significance of Clostridium difficile in Children Less Than 2 Years Old: A Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16941358" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Diarrhea etiology in a Children's Hospital Emergency Department: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25926302" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Co-infection as a confounder for the role of Clostridium difficile infection in children with diarrhoea: a summary of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32089179" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Impact of Multiplex Testing on the Identification of Pediatric Clostridiodes Difficile.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25247582" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Similar proportions of stool specimens from hospitalized children with and without diarrhea test positive for Clostridium difficile.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24785235" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : High colonization rate and prolonged shedding of Clostridium difficile in pediatric oncology patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17630999" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Clostridium difficile colitis in cystic fibrosis patients with and without lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26689599" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32925555" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Two-step Testing for Clostridioides Difficile is Inadequate in Differentiating Infection From Colonization in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16107901" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Clostridium difficile-associated diarrhea in 200 Canadian children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16518003" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Diagnostic role of stool culture&amp;toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25361022" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A hospital-based study of the clinical characteristics of Clostridium difficile infection in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25199038" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Novel risk factors for recurrent Clostridium difficile infection in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8043060" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Clostridium difficile colitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2696928" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Severe pseudomembranous enterocolitis in a child: case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7716002" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Rectal prolapse in children associated with Clostridium difficile infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18367964" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Intussusception associated with pseudomembranous colitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11601434" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Clinical quiz. An ileocolonic intussusception associated with C. difficile infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12089138" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : C difficile induced pneumatosis intestinalis in a neutropenic child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7724293" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Pneumatosis intestinalis in a child with AIDS and pseudomembranous colitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7282658" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Clostridium difficile associated with pseudomembranous colitis. Occurrence in a 12-week-old infant without prior antibiotic therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6799045" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Pseudomembranous colitis in a 5-week-old infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3958861" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Pseudomembranous colitis in a preterm neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1501036" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Perforated pseudomembranous colitis in the breast-fed infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6800456" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Pseudomembranous colitis in a 5-week-old infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11095331" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14599633" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Clostridium difficile infection in patients with unexplained leukocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7720439" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Severe Clostridium difficile colitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17245181" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11307591" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Extracolonic manifestations of Clostridium difficile infections. Presentation of 2 cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25245597" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Extraintestinal Clostridium difficile infections: a single-center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8933563" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Chronic osteomyelitis caused by Clostridium difficile in an adolescent with sickle cell disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9217461" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Reactive arthritis to Clostridium difficile in a child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19633524" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Severe Clostridium difficile colitis and reactive arthritis in a ten-year-old child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14769523" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Clostridium difficile-associated reactive arthritis in two children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27182697" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Epidemiology of Clostridium difficile Infection-Associated Reactive Arthritis in Children: An Underdiagnosed, Potentially Morbid Condition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23408679" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The epidemiology of Clostridium difficile infection in children: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27977555" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Recurrent Clostridium difficile Infection in Children: Patient Risk Factors and Markers of Intestinal Inflammation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29601446" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Analysis of Treatment Outcomes for Recurrent Clostridium difficile Infections and Fecal Microbiota Transplantation in a Pediatric Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16477549" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29462280" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17265394" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Recommendations for surveillance of Clostridium difficile-associated disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21976462" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Relapse versus reinfection: surveillance of Clostridium difficile infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11213096" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21058913" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24168983" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Predictors of first recurrence of Clostridium difficile infections in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26001313" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Risk Factors for Recurrent Clostridium difficile Infection in Children: A Nested Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23687578" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Clostridium difficile Infection in Children: Current State and Unanswered Questions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33564820" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Elevated White Blood Cell Count Does Not Predict Clostridium difficile Nucleic Acid Testing Results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8416409" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Diagnosis and treatment of Clostridium difficile colitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16623943" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Is Fecal Leukocyte Test a good predictor of Clostridium difficile associated diarrhea?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8577512" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Pseudomembranous colitis: CT findings in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16679120" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Ultrasound diagnosis of clinically undetected Clostridium difficile toxin colitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11222194" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Evaluating the CT diagnosis of Clostridium difficile colitis: should CT guide therapy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11222194" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Evaluating the CT diagnosis of Clostridium difficile colitis: should CT guide therapy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34003176" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27460910" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12425579" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Fulminant Clostridium difficile colitis without diarrhea: lack of emphasis in diagnostic guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31431428" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Clostridioides difficile: diagnosis and treatments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30160646" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : SHEA neonatal intensive care unit (NICU) white paper series: Practical approaches to Clostridioides difficile prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26517329" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing Decisions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27190172" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Impact of a Healthcare Provider Educational Intervention on Frequency of Clostridium difficile Polymerase Chain Reaction Testing in Children: A Segmented Regression Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8644759" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22911648" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Utility of perirectal swab specimens for diagnosis of Clostridium difficile infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19900734" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20071552" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29955859" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20686078" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Is repeat PCR needed for diagnosis of Clostridium difficile infection?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25626036" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Diagnosis and treatment of Clostridium difficile in adults: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25626036" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Diagnosis and treatment of Clostridium difficile in adults: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25588652" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27329497" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Using Multiplex Molecular Testing to Determine the Etiology of Acute Gastroenteritis in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27147712" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Detection of 23 Gastrointestinal Pathogens Among Children Who Present With Diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21899975" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Detection of toxigenic Clostridium difficile in pediatric stool samples: an evaluation of Quik Check Complete Antigen assay, BD GeneOhm Cdiff PCR, and ProGastro Cd PCR assays.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16517916" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17804652" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18032627" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Rapid and reliable diagnostic algorithm for detection of Clostridium difficile.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24007915" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23023352" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : The utility of repeat enzyme immunoassay testing for the diagnosis of Clostridium difficile infection: a systematic review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35801632" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35801632" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35801632" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10353927" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Impact of simple screening criteria on utilization of low-yield bacterial stool cultures in a Children's Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10776967" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Pseudomembranous viral colitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9161956" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Pseudomembranous colitis with Escherichia coli O157:H7.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17619469" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Salmonella pseudomembranous colitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/784931" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Shigella dysenteriae I: a forgotten cause of pseudomembranous colitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10565923" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
